Table 2.

FACS analysis

	Lp299		CURE21
	Before	After	Before	After
Fibrinogen	2.54 ± 0.20	2.70 ± 0.20	3.11 ± 0.30	2.87 ± 0.22
CD3	1.76 ± 0.16	1.34 ± 0.14	1.51 ± 0.09	1.56 ± 0.15
CD4	1.08 ± 0.17	0.73 ± 0.06	0.95 ± 0.05	0.96 ± 0.11
CD8	0.56 ± 0.18	0.49 ± 0.12	0.51 ± 0.08	0.55 ± 0.09
CD19	0.20 ± 0.03	0.15 ± 0.03	0.23 ± 0.04	0.20 ± 0.03
CD16+56	0.31 ± 0.06	0.33 ± 0.05	0.26 ± 0.04	0.33 ± 0.04
HLR-DR	0.31 ± 0.06	0.35 ± 0.05	0.26 ± 0.04	0.33 ± 0.04
HLR-DR/CD3	0.07 ± 0.01	0.10 ± 0.03	0.08 ± 0.02	0.08 ± 0.02
CD25 of CD4	0.04 ± 0.01	0.05 ± 0.01	0.04 ± 0.00	0.05 ± 0.01

Data presented as mean ± SEM. Fibrinogen: g/L; CD, HLR-DR: x10⁹/L